Selurampanel

DB12367InvestigationalSmall molecule

Selurampanel has been investigated in Adrenocortical Adenoma and Sarcoma, Endometrial Stromal.

Mechanism: Pharmacologically active on Glutamate receptor 1, Glutamate receptor 2, and Glutamate receptor 4
Curator reviewed
Formula / weight: C₁₆H₁₉N₅O₄S · 377.42 g/mol (avg)
Code names: BGG-492

Resolves to

Compound

Structure

InChIKeyMCECSFFXUPEPDB-UHFFFAOYSA-NSMILESCC(C)C1=C(C=C2C(NC(=O)N(NS(C)(=O)=O)C2=O)=C1)C1=CC=NN1C

Targets

What you can answer from here — as of July 07, 2026

5Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

8Clinical trialsPhase, status and sponsor resolved per trial

13+ReferencesStructured and connected to the statements they support

Which drugs share a target with Selurampanel, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.